MENU
+Compare
DBD
Stock ticker: NYSE
AS OF
Apr 3, 04:59 PM (EDT)
Price
$40.00
Change
-$4.74 (-10.59%)
Capitalization
1.29B

DBD Diebold Nixdorf Forecast, Technical & Fundamental Analysis

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries... Show more

DBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for DBD with price predictions
Apr 02, 2025

Momentum Indicator for DBD turns positive, indicating new upward trend

DBD saw its Momentum Indicator move above the 0 level on April 01, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator turned positive. In of the 27 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for DBD just turned positive on March 18, 2025. Looking at past instances where DBD's MACD turned positive, the stock continued to rise in of 16 cases over the following month. The odds of a continued upward trend are .

DBD moved above its 50-day moving average on April 01, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DBD advanced for three days, in of 107 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 22 cases where DBD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 10-day moving average for DBD crossed bearishly below the 50-day moving average on March 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DBD broke above its upper Bollinger Band on March 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.209) is normal, around the industry mean (30.907). P/E Ratio (0.000) is within average values for comparable stocks, (159.445). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.707). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (0.749) is also within normal values, averaging (59.276).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DBD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

View a ticker or compare two or three
DBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

DBD is expected to report earnings to fall 39.18% to 58 cents per share on May 13

Diebold Nixdorf DBD Stock Earnings Reports
Q1'25
Est.
$0.59
Q4'24
Missed
by $0.47
Q3'24
Missed
by $0.51
Q2'24
Beat
by $0.14
Q1'24
Beat
by $0.42
The last earnings report on February 12 showed earnings per share of 97 cents, missing the estimate of $1.44. With 44.45K shares outstanding, the current market capitalization sits at 1.29B.
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
N/A
Address
350 Orchard Avenue NE
Phone
+1 330 490-4000
Employees
21000
Web
https://www.dieboldnixdorf.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRDX43.590.13
+0.30%
MFS International Growth R6
PDSIX42.25N/A
N/A
PGIM Quant Solutions Large-Cap Index I
CPXRX14.24N/A
N/A
Columbia Mid Cap Index Inst2
GFVIX15.05N/A
N/A
Goldman Sachs Focused Value Inv
VAESX15.19N/A
N/A
Virtus KAR Emerging Markets Small-Cap A

DBD and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DBD has been loosely correlated with EGHT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if DBD jumps, then EGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBD
1D Price
Change %
DBD100%
+1.47%
EGHT - DBD
41%
Loosely correlated
+1.47%
PLUS - DBD
39%
Loosely correlated
+1.29%
DJCO - DBD
38%
Loosely correlated
+0.98%
GDRX - DBD
36%
Loosely correlated
+3.16%
YOU - DBD
36%
Loosely correlated
+2.09%
More